As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.

Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

China’s National Medical Products Administration (NMPA) has granted conditional approval for Hutchmed’s Tazverik ...

Wojciech Jurczak, MD, PhD, ​​discusses nemtabrutinib and its development for the treatment of follicular lymphoma.

A 66-year-old man was referred to our dermatology clinic for a 6-year history of a progressive pruritic rash, refractory to ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

Twenty-three gene expression levels were correlated with a high risk of disease progression, independently of the FLIPI-1 score and rituximab maintenance, in patients with follicular lymphoma.